CSL raises $2B but it could come at a cost

CSL is raising $2.14 billion (US$1.5 billion) by issuing corporate bonds, which could knock tens of millions from profit after tax due to higher interest rates.

To see the whole article please log in.

James Quintana Pearce

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here